Thorne HealthTech, Inc. (THRN) reported Q3 EPS of $0.12, $0.01 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $58.4 million versus the consensus estimate of $63.25 million.
GUIDANCE:
Thorne HealthTech, Inc. sees FY2022 EPS of $0.34-$0.37, versus the consensus of $0.36. Thorne HealthTech, Inc. sees FY2022 revenue of $232-235 million, versus the consensus of $238 million.